Clinical Trials
9 trialsNCT05907954 2026-03-16
(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma
IDEAYA Biosciences
Phase 2 Active not recruiting
NCT07021495 2025-08-19
SKINERGY
Leiden University Medical Center
Recruiting
NCT01490632 2019-09-27
A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis
Eli Lilly and Company
Phase 2 Completed
NCT01107457 2019-09-24
A Study in Participants With Moderate to Severe Psoriasis
Eli Lilly and Company
Phase 2 Completed
NCT02634931 2019-02-20
Long-term Trial of Topical Sirolimus to Angiofibroma in Patient With Tuberous Sclerosis Complex
Nobelpharma
Phase 3 Completed
NCT02908347 2019-01-23
Study to Evaluate Safety and Efficacy of Oral MP1032 in Psoriasis Patients
MetrioPharm AG
Phase 2 Completed
NCT01241591 2018-12-26
A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Pfizer
Phase 3 Completed
NCT02635789 2017-02-02
Phase III Trial of Topical Formulation of Sirolimus to Skin Lesions in Patients With Tuberous Sclerosis Complex (TSC)
Nobelpharma
Phase 3 Completed
NCT02201524 2016-10-05
Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis
Pfizer
Phase 2 Terminated